Today: 21 May 2026
Glencore stock steadies as copper hits record highs — what to watch next for GLEN.L
7 January 2026
1 min read

Glencore stock steadies as copper hits record highs — what to watch next for GLEN.L

London, Jan 7, 2026, 08:38 GMT — Regular session

  • Glencore shares were little changed in early London trade after a two-day rally.
  • Copper’s record run and tariff concerns have kept miners in focus.
  • Investors are looking ahead to Glencore’s late-January production update and February results.

Glencore shares edged lower in early London trade on Wednesday, after two sessions of gains that tracked copper’s record run. The stock was down 0.15 pence, or about 0.04%, at 427.80 pence by 0820 GMT.

Copper has been the immediate driver for miners this week after prices surged above $13,000 a metric ton, reviving talk of tight supply and the need for higher prices to unlock new projects. “Copper prices need to rise further,” SP Angel analyst John Meyer said. Concord Resources research director Duncan Hobbs said metals are rallying on “critical minerals and security of supply chains.” Reuters

Tariff risk has added fuel. U.S. copper futures have traded at a premium to the London Metal Exchange benchmark, a gap that has encouraged traders to ship metal into the United States; a decision on possible U.S. copper tariffs has been deferred until June, Reuters columnist Andy Home wrote.

Glencore closed up 2.06% on Tuesday and 2.57% on Monday, putting the shares near the top of their one-year range, MarketScreener data showed. The stock has traded between 205 pence and 428.75 pence over the past year, leaving 430p as a nearby technical ceiling traders are watching.

The risk for bulls is that copper gives back gains if the tariff narrative cools or demand signals soften, while sharp price swings can also hit trading margins across the sector. A pullback in base metals would likely drag diversified miners with it, even if company-specific news stays light.

Glencore’s next scheduled catalysts are its production report and resources and reserves update on Jan. 29, followed by preliminary annual results on Feb. 18, the company’s calendar shows. Investors will be looking for production trends, cost direction and any fresh steer on capital returns.

Stock Market Today

  • Teradyne, Kulicke and Soffa, Impinj, Microchip, IPG Photonics Stocks Slide on U.S.-China Semiconductor Summit Outcome
    May 21, 2026, 2:58 AM EDT. Shares of Teradyne, Kulicke and Soffa, Impinj, Microchip Technology, and IPG Photonics dropped sharply following the U.S.-China summit, which ended without key breakthroughs on semiconductor exports. Expectations for U.S. approval of Nvidia's H200 chip shipments to China were unmet, disappointing investors. U.S. Trade Representative Jamieson Greer indicated semiconductors were not a negotiation focus, dampening near-term optimism. Despite the sell-off, IPG Photonics' stock, known for volatility, remains down significantly from its 52-week high but has gained 34.3% year-to-date. Market reactions highlight cautious sentiment amid geopolitical tensions, with analysts skeptical about swift comprehensive deals due to national security concerns.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Cipla share price slides after USFDA flags Pharmathen: what the Form 483 says
Previous Story

Cipla share price slides after USFDA flags Pharmathen: what the Form 483 says

UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings
Next Story

UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings

Go toTop